CMS proposes ‘good’ physician payment update in new rule

The Centers for Medicare & Medicaid Services' (CMS) CY2026 Physician Payment Rule proposes a net 3.3% payment update for nursing home services, a significant improvement from last year's negative adjustment, alongside expanded telehealth provisions including permanent removal of frequency limitations for nursing facility visits. However, the rule introduces proposed 'productivity' and 'efficiency' adjustments to payment codes that raise concerns among stakeholders, and notably implements a major change to skin substitute reimbursement, aiming for 90% savings due to alleged 'abusive pricing practices.' Additionally, the rule signals a strategic shift towards wellness and chronic disease prevention, while seeking to simplify regulatory processes, impacting long-term care providers and Medicare spending dynamics.

Analysis

The Centers for Medicare & Medicaid Services' (CMS) proposed CY2026 Physician Payment Rule introduces a significant net positive payment update of 3.3% for services in nursing homes, a stark reversal from the previous year's negative 2.93% adjustment. This increase is a composite of a 0.25% MACRA update, a 2.5% legislative boost, and an uncharacteristically positive 0.55% budget neutrality adjustment. However, stakeholder optimism is tempered by proposed countervailing measures, including a 'productivity adjustment' and a -2.5% 'efficiency adjustment' to certain work relative value units, which could erode the headline rate increase and strain provider resources. The rule also codifies a major expansion of telehealth, permanently removing frequency limitations for subsequent nursing facility visits and streamlining the approval process for new telehealth services—a clear win for virtual care providers. In a targeted cost-containment effort, CMS is proposing a fundamental change to skin substitute reimbursement, reclassifying them as billable supplies to achieve an estimated 90% in savings, directly addressing what it termed a fortyfold spending increase driven by 'abusive pricing practices.' This signals a significant disruption for manufacturers in that niche. Overall, the rule reflects a strategic pivot by CMS toward chronic care management and regulatory simplification, while aggressively managing costs in specific high-growth areas.

Key Decisions for Investors

• Investors with exposure to long-term care operators should view the proposed 3.3% payment update as a considerable tailwind, but must closely monitor the potential impact of the negative 'productivity' and 'efficiency' adjustments on specific company margins before revising models.
• The permanent expansion of telehealth reimbursement in nursing facilities solidifies the long-term growth thesis for telehealth platform providers; prioritize companies with an established presence in the geriatric and long-term care sectors.
• Immediately re-evaluate positions in medical technology or biotech companies focused on skin substitutes, as the proposed 90% reimbursement cut represents a direct and severe threat to their revenue streams and market viability.
• Monitor developments through the September 12 comment period, as lobbying efforts could alter the final rule, particularly concerning the negative payment adjustments that remain the largest variable for providers' net financial outcome.